MariMed Inc. (OTCMKTS:MRMD) Short Interest Update

MariMed Inc. (OTCMKTS:MRMD) was the recipient of a large increase in short interest in May. As of May 29th, there was short interest totaling 64,138 shares, an increase of 1,827.8% from the May 14th total of 3,327 shares. Based on an average daily volume of 1,254,952 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

MariMed Stock Down 2.7%

Shares of MRMD traded down $0.00 during mid-day trading on Tuesday, reaching $0.07. The company had a trading volume of 624,564 shares, compared to its average volume of 645,909. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. The firm has a 50-day moving average price of $0.08 and a 200 day moving average price of $0.08. MariMed has a 52 week low of $0.06 and a 52 week high of $0.23. The company has a market capitalization of $29.14 million, a price-to-earnings ratio of -2.43 and a beta of 1.30.

MariMed (OTCMKTS:MRMD) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.The firm had revenue of $39.48 million for the quarter, compared to analysts’ expectations of $38.75 million. On average, sell-side analysts forecast that MariMed will post -0.04 EPS for the current year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.